Skip to main content

GOLDMAN SACHS GROUP INC

Position in ACIU — AC Immune SA

CIK 886982 NEW YORK, NY

Position in ACIU

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$59,488
+$1,226 QoQ
Shares Held
21,632
+16.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACIU Over Time

Shares Held

Position Value (USD)

Derivatives in ACIU

reported options exposure · as of Sep 30, 2020
CallValue
$198,616
CallShares
40,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ACIU ranks #351 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACIU

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $59,488 21,632
2025-12-31 $58,262 18,555
2025-09-30 $36,515 12,635
2025-06-30 $21,049 10,369
2024-09-30 $47,843 12,657
2024-06-30 $53,182 13,329
2024-03-31 $69,882 23,609
2023-12-31 $86,450 17,290
2022-12-31 $38,488 18,867
2022-09-30 $83,983 26,577
2022-06-30 $104,264 28,882
2022-03-31 $115,228 28,807
2021-12-31 $131,783 26,623
2021-09-30 $226,066 33,691
2021-06-30 $264,854 33,399
2021-03-31 $422,720 55,548
2020-12-31 $266,715 51,589
2020-09-30 $198,616 40,700
2020-09-30 $191,886 39,321
2020-06-30 $394,324 58,592
2020-03-31 $182,458 26,405